top of page

Common forms of cancer

Cancer is a complex group of diseases that can affect various parts of the body. There are many different types of cancer, and each type may have unique symptoms, screening recommendations, and ages at which screening should begin.

 

Disclaimer:

The information on this page is for general knowledge and should not be considered a substitute for professional medical advice. Consult a healthcare provider for personalized guidance. We aim to provide accurate information, but medical knowledge evolves, and the content may not always reflect the latest research. Reliance on this information is at your own risk, and we are not liable for any consequences. By using this website, you accept these terms. If you have medical concerns, consult a healthcare professional.

Here's an outline of some common forms of cancer:

Ovarian Cancer


Ovarian cancer is a type of cancer that begins in the ovaries, which are part of the female reproductive system. The ovaries are responsible for producing eggs (ova) and female sex hormones, including estrogen and progesterone. Ovarian cancer typically develops when normal cells in the ovaries undergo genetic mutations, causing them to grow and divide uncontrollably, forming a tumor.

Screening
Associated Forms of Cancers
Ribbon Color:

Teal

Awareness Month:

September

Symptoms:

Ovarian cancer is often called the "silent killer" because it can be challenging to detect in its early stages due to the lack of noticeable symptoms. When symptoms do appear, they can be vague and easily attributed to other common conditions. Some of the common symptoms of ovarian cancer include:

Abdominal bloating or swelling
Pelvic pain or discomfort
Changes in appetite, such as feeling full quickly or difficulty eating
Increased urgency or frequency of urination
Unexplained weight loss
Fatigue
Changes in bowel habits, such as constipation or diarrhea

More Info:
Ovarian cancer can be classified into different types based on the type of cells it originates from, including epithelial tumors (the most common type), germ cell tumors, and stromal tumors. Epithelial ovarian cancer is the most common and is often diagnosed in older women. Early diagnosis and treatment are crucial for improving the prognosis of ovarian cancer. Unfortunately, due to the lack of specific symptoms in the early stages, it is often diagnosed at an advanced stage. Treatment options for ovarian cancer typically include surgery to remove the tumor and surrounding tissue, chemotherapy, and sometimes radiation therapy or targeted therapy, depending on the stage and type of cancer. It's important for women to be aware of the potential symptoms of ovarian cancer and to seek medical attention if they experience persistent and unexplained changes in their health. Regular gynecological check-ups and discussions with healthcare providers about family history and risk factors can also aid in early detection and prevention.
Multiple Myeoloma

Multiple myeloma is a type of cancer that affects plasma cells, a type of white blood cell that plays a crucial role in the immune system. It is characterized by the abnormal and uncontrolled growth of plasma cells within the bone marrow, leading to the formation of tumors in bone tissue. Multiple myeloma is also sometimes referred to as myeloma or plasma cell myeloma.

Screening
Multiple myeloma is typically detected through a combination of clinical evaluations, laboratory tests, and imaging studies. If your healthcare provider suspects multiple myeloma based on your symptoms or medical history, they will perform various tests to confirm the diagnosis and assess the extent of the disease. Here is an overview of the diagnostic methods commonly used for multiple myeloma: Blood and Urine Tests: Complete Blood Count (CBC): A CBC measures the levels of different blood components, including red blood cells, white blood cells, and platelets. Multiple myeloma can lead to anemia (low red blood cell count) and other abnormalities. Blood Chemistry Panel: This test assesses kidney function, calcium levels, and other markers in the blood. Elevated calcium levels may indicate bone involvement. Serum Protein Electrophoresis: This test examines the different types of proteins in the blood, including the presence of monoclonal proteins (M proteins) produced by myeloma cells. Urinalysis: A urine test can detect abnormal proteins, such as Bence Jones proteins, which are sometimes produced by myeloma cells and excreted in the urine. Bone Marrow Biopsy: A bone marrow biopsy involves the removal of a small sample of bone marrow tissue, usually from the hip bone (pelvic bone). This sample is then examined under a microscope to check for the presence of myeloma cells and assess the percentage of plasma cells in the bone marrow. Imaging Studies: X-rays: X-rays can reveal bone lesions and fractures associated with multiple myeloma. CT (Computed Tomography) Scan: CT scans provide detailed cross-sectional images of the body and are often used to assess the extent of bone involvement and detect other abnormalities. MRI (Magnetic Resonance Imaging): MRI scans can help visualize bone and soft tissue involvement, especially in the spine. PET (Positron Emission Tomography) Scan: PET scans may be used to identify areas of increased metabolic activity, which can help assess disease progression. Monoclonal Antibody Tests: Some specialized tests, such as flow cytometry and immunohistochemistry, can identify and characterize specific types of myeloma cells based on the expression of certain cell surface markers. Cytogenetic and Molecular Testing: These tests examine the genetic and molecular characteristics of myeloma cells to provide information about disease prognosis and guide treatment decisions.
Associated Forms of Cancers
Ribbon Color:

Burgandy

Awareness Month:

March

Symptoms:

More Info:
Here are some key points about multiple myeloma: Plasma Cells: Plasma cells are a type of white blood cell responsible for producing antibodies (immunoglobulins) that help the body fight infections. In multiple myeloma, these plasma cells become cancerous and produce abnormal antibodies, known as monoclonal proteins or M proteins. Bone Involvement: Multiple myeloma often leads to the weakening of bones and the development of bone lesions. This can cause bone pain, fractures, and other skeletal problems. The condition may also result in elevated levels of calcium in the blood. Symptoms: Common symptoms of multiple myeloma may include bone pain, especially in the back or ribs, fatigue, frequent infections, anemia (low red blood cell count), kidney problems, and unexplained weight loss. Some individuals may not experience noticeable symptoms in the early stages of the disease. Diagnosis: Diagnosis typically involves a combination of blood tests, urine tests, bone marrow biopsy, and imaging studies (X-rays, CT scans, or MRI scans) to confirm the presence of multiple myeloma, assess its stage, and monitor bone involvement. Staging: Multiple myeloma is staged based on various factors, including the levels of abnormal antibodies in the blood, the presence of bone lesions, and other clinical indicators. Staging helps determine the extent of the disease and guides treatment decisions. Treatment: Treatment for multiple myeloma depends on the stage and characteristics of the cancer, as well as the individual's overall health. Common treatment options may include chemotherapy, immunomodulatory drugs, targeted therapy, stem cell transplantation, radiation therapy, and supportive therapies to manage symptoms and complications. Prognosis: The prognosis for multiple myeloma varies depending on the stage at diagnosis and the effectiveness of treatment. While multiple myeloma is generally considered incurable, many individuals can achieve remission or manage the disease effectively with treatment. Advances in treatment options have improved survival rates in recent years. Risk Factors: Factors that may increase the risk of developing multiple myeloma include age (it is more common in older adults), a family history of the disease, certain genetic factors, exposure to radiation, and certain occupational exposures. It's important for individuals who experience symptoms or have risk factors for multiple myeloma to seek medical evaluation and diagnosis. Early detection and prompt treatment can improve outcomes and quality of life for individuals with this cancer. Treatment plans are often tailored to each person's specific circumstances, and close monitoring is essential for managing the disease over time.
Endometrial Cancer

Endometrial cancer, also known as uterine cancer, is a type of cancer that originates in the lining of the uterus, called the endometrium. The uterus is a female reproductive organ where a fertilized egg implants and grows during pregnancy. Endometrial cancer is the most common type of uterine cancer and primarily affects postmenopausal women, although it can occur in women of all ages.

Screening
Endometrial cancer is detected through a combination of medical evaluations and diagnostic tests. If you or your healthcare provider suspect endometrial cancer based on symptoms or risk factors, the following steps are typically taken to confirm the diagnosis: Medical History and Physical Examination: Your healthcare provider will begin by discussing your medical history and conducting a thorough physical examination, including a pelvic exam. During the pelvic exam, they will examine the uterus and surrounding tissues for any abnormalities. Transvaginal Ultrasound: A transvaginal ultrasound is often one of the first imaging tests used to evaluate the uterus. A probe is inserted into the vagina, allowing for a close-up view of the uterus and its lining (endometrium). This test can help identify abnormalities, such as thickening of the endometrial lining. Endometrial Biopsy: If the transvaginal ultrasound suggests endometrial thickening or other abnormalities, your healthcare provider may recommend an endometrial biopsy. During this procedure, a small sample of tissue from the lining of the uterus is collected for laboratory analysis. There are different methods for obtaining the biopsy, including: Dilation and Curettage (D&C): A common method where a thin instrument (curette) is used to scrape away a small amount of tissue from the uterine lining. Hysteroscopy: A thin, lighted scope (hysteroscope) is inserted through the cervix into the uterus, allowing direct visualization of the endometrial tissue. Biopsy samples can be taken during hysteroscopy. Imaging Studies: In some cases, additional imaging studies may be ordered to determine the extent of cancer or to assess if it has spread. These may include: Computed Tomography (CT) Scan: This scan provides detailed cross-sectional images of the pelvis and abdomen. Magnetic Resonance Imaging (MRI): MRI can offer a more detailed view of the uterus and surrounding structures. Chest X-ray: To check for signs of metastasis (spread) to the lungs. Positron Emission Tomography (PET) Scan: In advanced cases, a PET scan may be recommended to detect possible distant metastases. CA-125 Blood Test: CA-125 is a tumor marker that can be elevated in some cases of endometrial cancer, but it is not specific to this cancer. It may be used to monitor the response to treatment and assess disease progression. Once the diagnosis is confirmed, the cancer is staged to determine its extent and spread within the uterus and to nearby organs or lymph nodes. The stage of endometrial cancer plays a crucial role in determining the appropriate treatment plan.
Associated Forms of Cancers
Ribbon Color:

Peach

Awareness Month:

September

Symptoms:

Common symptoms of endometrial cancer may include:

Abnormal vaginal bleeding or spotting, particularly after menopause.
Unusually heavy or prolonged menstrual periods.
Pelvic pain or discomfort.
Pain during sexual intercourse.
Unexplained weight loss.

More Info:
Risk Factors: Several factors can increase the risk of developing endometrial cancer, including: Age: The risk increases with age, and the majority of cases occur in postmenopausal women. Hormone Imbalance: An excess of estrogen relative to progesterone, often seen in conditions like polycystic ovary syndrome (PCOS) or obesity, can raise the risk. Obesity: Excess body fat can increase estrogen production, contributing to the development of endometrial cancer. Hormone Replacement Therapy (HRT): Long-term use of estrogen-only hormone therapy without progestin in postmenopausal women may increase the risk. Hereditary Conditions: Certain hereditary syndromes, such as Lynch syndrome, can predispose individuals to endometrial cancer. Tamoxifen Use: This medication, often used in breast cancer treatment and prevention, can increase the risk of endometrial cancer. Diabetes: Women with diabetes may have a higher risk. Diagnosis: Diagnosis typically involves a combination of: Pelvic examination. Transvaginal ultrasound to visualize the uterine lining. Endometrial biopsy, where a small sample of the uterine lining is taken for laboratory analysis. Dilation and curettage (D&C), which involves scraping away a small amount of tissue from the uterus lining for examination. Staging: Once diagnosed, endometrial cancer is staged to determine the extent of its spread. Stages range from I (limited to the uterus) to IV (spread to distant organs). Treatment: Treatment options depend on the cancer's stage, grade, and the overall health of the patient. Common treatments may include: Surgery: Hysterectomy (removal of the uterus), often with the removal of nearby lymph nodes and other tissues. Radiation therapy: External beam radiation or brachytherapy may be used to target cancer cells. Chemotherapy: Administered either before surgery (neoadjuvant) or after surgery (adjuvant) to kill cancer cells. Hormone therapy: For certain types of endometrial cancer that are hormone receptor-positive. Prognosis: The prognosis for endometrial cancer varies based on the stage at diagnosis. Early-stage cancers typically have a better prognosis, with a high chance of cure. Advanced-stage cancers may require more aggressive treatment and may have a lower survival rate. It's essential for individuals to seek medical attention if they experience any unusual vaginal bleeding or other symptoms associated with endometrial cancer. Early detection and treatment can significantly improve outcomes. Additionally, maintaining a healthy lifestyle, managing risk factors like obesity and diabetes, and discussing hormone therapy options with healthcare providers can help reduce the risk of endometrial cancer.
Cervical Cancer

Cervical cancer is a type of cancer that develops in the cervix, which is the lower part of the uterus (womb) that connects to the vagina. Cervical cancer typically begins when normal cells in the cervix undergo genetic mutations, leading to the uncontrolled growth of abnormal cells. Over time, these cells can form a tumor and may spread to other parts of the body if left untreated.

Screening
Screening: Pap smear (Pap test) and HPV (human papillomavirus) testing are common methods. Age to Begin Screening: Typically starts at age 21 with regular intervals, but the frequency may vary based on age and previous results.
Associated Forms of Cancers
There are three main types of skin cancer: Basal Cell Carcinoma (BCC): Basal cell carcinoma is the most common type of skin cancer. It typically develops in the basal cells of the epidermis, which is the top layer of the skin. BCC is usually slow-growing and rarely spreads to other parts of the body. It often appears as a pearly bump, a pinkish patch of skin, or a sore that doesn't heal. Squamous Cell Carcinoma (SCC): Squamous cell carcinoma also originates in the skin's outer layer but is more likely to spread than basal cell carcinoma if left untreated. It often appears as a scaly, red patch, a wart-like growth, or a sore that doesn't heal. Melanoma: Melanoma is a less common but more aggressive type of skin cancer that develops in melanocytes, the cells responsible for producing melanin, the pigment that gives color to the skin, hair, and eyes. Melanoma is more likely to metastasize (spread to other parts of the body) if not detected and treated early. It can manifest as an irregularly shaped, dark-colored mole or a new spot on the skin.
Ribbon Color:

Teal & White

Awareness Month:

January

Symptoms:

Often asymptomatic in early stages; later stages may cause abnormal vaginal bleeding, pelvic pain, or pain during intercourse. Common symptoms of cervical cancer may include:

Abnormal vaginal bleeding, such as bleeding between periods, after sexual intercourse, or after menopause.
Pelvic pain or discomfort.
Pain during sexual intercourse.
Unexplained weight loss and fatigue (in advanced stages).

More Info:
Risk factors for skin cancer include excessive sun exposure, especially if it leads to sunburns, having fair skin that burns easily, a family history of skin cancer, a weakened immune system, and a history of previous skin cancer. Prevention and early detection are crucial in managing skin cancer. This involves protecting your skin from excessive UV radiation by wearing sunscreen, protective clothing, and avoiding tanning beds. Regular self-exams and professional dermatological examinations can help detect skin cancer in its early stages when it's more treatable. Treatment options for skin cancer include surgical removal (excision), Mohs surgery (a precise surgical technique for certain types of skin cancer), radiation therapy, and, in some cases, chemotherapy or immunotherapy. If you notice any changes in your skin, such as the development of new moles, changes in the appearance of existing moles, or skin abnormalities that don't heal, it's essential to consult a healthcare professional or dermatologist promptly for evaluation and, if necessary, further testing or treatment. Early diagnosis and intervention significantly improve the prognosis for skin cancer. Cervical cancer often develops slowly over a period of several years, and it typically goes through precancerous stages before becoming invasive cancer. These precancerous changes can be detected through regular cervical screening tests, such as the Pap smear (Pap test) and HPV testing. Detecting and treating these precancerous changes can prevent the development of cervical cancer. The stages of cervical cancer range from early stages, where the cancer is confined to the cervix, to advanced stages, where it has spread to nearby tissues or other parts of the body. Treatment options for cervical cancer depend on the stage of the disease and may include surgery, radiation therapy, chemotherapy, targeted therapy, and immunotherapy.
Lung Cancer

Lung cancer is a type of cancer that starts in the lungs. It is the leading cause of cancer deaths worldwide.

Screening
Screening: Low-dose CT scans are recommended for individuals at high risk, such as long-term smokers. Age to Begin Screening: Usually recommended for current or former heavy smokers aged 55-80 with a significant smoking history.
Associated Forms of Cancers
There are two primary types of lung cancer: Non-Small Cell Lung Cancer (NSCLC): This is the most common type, accounting for about 85% of all lung cancer cases. NSCLC can be further categorized into subtypes, including adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. Each subtype may have distinct characteristics and treatment approaches. Small Cell Lung Cancer (SCLC): Small cell lung cancer is less common but tends to be more aggressive and fast-growing than NSCLC. It often starts in the bronchi and can quickly spread to other parts of the body. SCLC is typically divided into two stages: limited-stage (confined to one lung and nearby lymph nodes) and extensive-stage (spread to other areas of the chest or distant organs).
Ribbon Color:

White

Awareness Month:

November

Symptoms:

Common symptoms of lung cancer may include:

Persistent cough, often with blood.
Chest pain that worsens with deep breathing or coughing.
Shortness of breath.
Unexplained weight loss.
Hoarseness.
Fatigue.
Recurrent lung infections, like bronchitis or pneumonia.

More Info:
Risk factors for lung cancer include smoking (both active and passive or secondhand smoke exposure), exposure to carcinogens such as asbestos, radon gas, and certain industrial chemicals, a family history of lung cancer, and a history of previous lung diseases like chronic obstructive pulmonary disease (COPD). Diagnosing lung cancer typically involves imaging tests such as chest X-rays or CT scans, as well as tissue sampling (biopsy) to confirm the cancer type and stage. Once diagnosed, the treatment options for lung cancer depend on the cancer's type, stage, and the overall health of the patient. Treatments may include surgery, radiation therapy, chemotherapy, targeted therapy (for specific genetic mutations in NSCLC), and immunotherapy. Prevention of lung cancer primarily involves avoiding tobacco smoke, including quitting smoking and avoiding exposure to secondhand smoke. Additionally, reducing exposure to environmental carcinogens, like radon gas and asbestos, can help lower the risk of developing lung cancer. Early detection through lung cancer screening with low-dose CT scans is recommended for individuals at high risk, such as current or former heavy smokers aged 55-80, to identify lung cancer at an early and potentially more treatable stage.
Breast Cancer

Breast cancer is a type of cancer that forms in the cells of the breasts. It is the most common cancer among women worldwide.

Screening
Screening: Mammography is the primary screening method. Self-breast exams and clinical breast exams may also be recommended. Age to Begin Screening: Typically, mammography screening begins at age 40 for women with an average risk of breast cancer, but individual recommendations may vary based on family history and risk factors.
Associated Forms of Cancers
Types of Breast Cancer: Ductal Carcinoma in Situ (DCIS): This is a non-invasive cancer where abnormal cells are found in the lining of a breast duct but have not spread outside the duct. DCIS is highly treatable. Invasive Ductal Carcinoma (IDC): The most common type of breast cancer, IDC starts in the milk ducts and invades nearby tissues in the breast. Invasive Lobular Carcinoma (ILC): ILC begins in the milk-producing glands (lobules) and can also spread to surrounding tissues. Triple-Negative Breast Cancer: This type lacks estrogen receptors, progesterone receptors, and HER2/neu receptors, making it more challenging to treat with targeted therapies. HER2-Positive Breast Cancer: This type overexpresses the HER2/neu protein and may respond well to targeted therapies. Hormone Receptor-Positive Breast Cancer: These cancers have receptors for estrogen and/or progesterone and may respond to hormone therapy.
Ribbon Color:

Pink

Awareness Month:

October

Symptoms:

Common symptoms of breast cancer may include a breast lump or mass, changes in breast size or shape, nipple discharge (other than breast milk), nipple inversion or changes, skin changes on the breast (redness, dimpling, puckering), and breast pain (though breast cancer is not typically painful).

More Info:
Diagnosis: Diagnosis usually involves a combination of imaging tests (mammograms, ultrasounds, MRIs) and a biopsy, which is the removal of a small tissue sample for examination under a microscope. Breast cancer is staged based on its size, spread to nearby lymph nodes, and metastasis to distant organs. Treatment: Treatment options for breast cancer depend on the cancer's type, stage, and other factors but commonly include surgery (lumpectomy or mastectomy), radiation therapy, chemotherapy, hormone therapy (for hormone receptor-positive cancers), targeted therapy (for HER2-positive cancers), and immunotherapy in some cases. Prevention: Reducing the risk of breast cancer can involve lifestyle choices like maintaining a healthy weight, regular physical activity, limiting alcohol consumption, and avoiding smoking. Additionally, some individuals with a high risk of breast cancer may consider preventive measures, such as prophylactic surgery or chemoprevention, under the guidance of healthcare professionals. Early detection through regular breast self-exams, clinical breast exams, and mammograms is crucial for improving the chances of successful treatment. It's important for individuals to be aware of their breast health, discuss any concerns with healthcare providers, and follow recommended screening guidelines based on their age and risk factors.
Colorectal Cancer

Colorectal cancer, often referred to as colon cancer or rectal cancer, is a type of cancer that begins in the colon or rectum, which are parts of the digestive system responsible for processing and eliminating waste from the body. Colorectal cancer typically starts as a growth of abnormal cells known as polyps in the inner lining of the colon or rectum and can then develop into cancer over time.

Screening
Screening for colorectal cancer is essential for early detection and prevention. Common screening methods include colonoscopy, sigmoidoscopy, fecal occult blood tests, and stool DNA tests. The age to begin screening and the recommended frequency can vary based on individual risk factors but typically starts at age 45 or 50 for individuals at average risk.
Associated Forms of Cancers
Types of Colorectal Cancer: Colon Cancer: This cancer originates in the colon, which is the large intestine. It can occur in any part of the colon. Rectal Cancer: Rectal cancer begins in the rectum, which is the last part of the large intestine just before the anus.
Ribbon Color:

Dark Blue

Awareness Month:

March

Symptoms:

Common symptoms of colorectal cancer may include a change in bowel habits (diarrhea or constipation), blood in the stool, abdominal pain or cramping, unexplained weight loss, fatigue, and a feeling that the bowel does not completely empty.

More Info:
Diagnosis: If a screening test indicates abnormalities, or if a person experiences symptoms, further diagnostic tests like colonoscopy or biopsy may be performed to confirm the presence of colorectal cancer and determine its stage. Treatment: Treatment for colorectal cancer depends on its stage and location but commonly includes surgery to remove the cancerous tissue, chemotherapy, radiation therapy, targeted therapy (for specific genetic mutations), and immunotherapy. In some cases, a combination of these treatments may be recommended. Prevention: Lifestyle modifications, such as maintaining a healthy diet rich in fruits and vegetables, regular exercise, limiting the consumption of red and processed meats, avoiding smoking, and limiting alcohol intake, can help reduce the risk of colorectal cancer. Additionally, individuals with a family history or certain risk factors may need to undergo more frequent screening or genetic counseling. Colorectal cancer is highly treatable when detected at an early stage. Therefore, regular screening, as well as awareness of symptoms and risk factors, is crucial for early diagnosis and improved outcomes. Consultation with a healthcare provider is essential to determine the appropriate screening schedule and prevention strategies based on individual risk factors.
Skin Cancer

Skin cancer is a type of cancer that begins in the skin's cells. The skin is the body's largest organ and plays a crucial role in protecting the body from environmental factors, including harmful ultraviolet (UV) radiation from the sun. Skin cancer typically develops when skin cells undergo abnormal changes and multiply uncontrollably.

Screening
Screening: Regular skin self-exams and professional dermatological examinations. Age to Begin Screening: No specific age to begin regular screening; it's important to monitor your skin for changes throughout life, especially if you have risk factors like a family history of skin cancer or extensive sun exposure.
Associated Forms of Cancers
Basal Cell Carcinoma (BCC): Basal cell carcinoma is the most prevalent type of skin cancer. It typically develops in the basal cells of the epidermis, the top layer of the skin. BCC is usually slow-growing and rarely spreads to other parts of the body. It often appears as a pearly bump, a pinkish patch of skin, or a sore that doesn't heal. Squamous Cell Carcinoma (SCC): Squamous cell carcinoma also originates in the skin's outer layer but is more likely to spread than basal cell carcinoma if left untreated. It often appears as a scaly, red patch, a wart-like growth, or a sore that doesn't heal. Melanoma: Melanoma is a less common but more aggressive type of skin cancer that develops in melanocytes, the cells responsible for producing melanin, the pigment that gives color to the skin, hair, and eyes. Melanoma is more likely to metastasize (spread to other parts of the body) if not detected and treated early. It can manifest as an irregularly shaped, dark-colored mole or a new spot on the skin.
Ribbon Color:

Black

Awareness Month:

May

Symptoms:

Changes in the size, shape, or color of moles or skin lesions, new growths, sores that don't heal.

More Info:
Risk factors for skin cancer include excessive sun exposure, especially if it leads to sunburns, having fair skin that burns easily, a family history of skin cancer, a weakened immune system, and a history of previous skin cancer. Prevention and early detection are crucial in managing skin cancer. This involves protecting your skin from excessive UV radiation by wearing sunscreen, protective clothing, and avoiding tanning beds. Regular self-exams and professional skin examinations can help detect skin cancer in its early stages when it's more treatable. Treatment options for skin cancer include surgical removal (excision), Mohs surgery (a precise surgical technique for certain types of skin cancer), radiation therapy, and, in some cases, chemotherapy or immunotherapy. If you notice any changes in your skin, such as the development of new moles, changes in the appearance of existing moles, or skin abnormalities that don't heal, it's essential to consult a healthcare professional or dermatologist promptly for evaluation and, if necessary, further testing or treatment. Early diagnosis and intervention significantly improve the prognosis for skin cancer.
bottom of page